Develop
a range of high-throughput, multi-residue (measurement of at
least four coccidiostat residues) and user-friendly screening tests
based on time-resolved fluoroimmunoassay.
Develop
chemical confirmatory methods to support the screening assay
development programme. These methods will be based on LC-MS and/or GC-MS.
To
validate the assays using criteria laid down in the annex to
EC directive 96/23/EEC.
Organise
Technology Transfer events for the appropriate end-users of the
methods.
"The content of the present publication is the sole responsibility of its
publisher(s) and in no way represent the views of the Commission and its
services."
